Pharmaceutical Excipients Development
Pharmaceutical excipients have a vital role in formulations. Choosing of excipients is an important in Drug Development. Excipients will have the ideal pharmacokinetic properties. Existing regulations and guidelines indicate that new (novel) excipients should be treated as new chemical entities with full toxicological evaluation. Excipients are now known to have defined functional roles in pharmaceutical dosage forms. Excipients can influence both safety and efficacy outcomes of the drugs. Excipients play a vital role in Drug delivery systems. Excipients are designed to be biologically inactive, removing this barrier could provide a potentially immediate, low-risk solution to the current shortage of new drug formulations.
The global excipient market size is expected to grow to USD 6.9 billion by 2025, a compound annual growth rate (CAGR) of 6.02% from 2017 to 2025.
- Regulation of Pharmaceutical Excipients
- Excipients used in Oral-Liquid formulations
- Excipient Interactions
- Emerging excipients in Parenteral Medications
- Excipients Quality Assurance
Related Conference of Pharmaceutical Excipients Development
Pharmaceutical Excipients Development Conference Speakers
Recommended Sessions
- Bioavailability and Bioequivalence Studies
- Challenges in Drug Administration
- Drug Delivery approaches for Parenterals
- Drug Delivery Devices: Approaches and Manufacturing
- Drug Delivery Technologies
- Drug Designing and Development
- Entrepreneurs Investment Meet
- Novel Drug Delivery Systems
- Novel Drug Formulation Procedures
- Pharmaceutical Analysis Methods
- Pharmaceutical Excipients Development
- Pharmaceutical Formulations: Academic and Industry Perspective
- Pharmaceutical Formulations: Types and Novelties
- Pharmaceutical IPR and Regulatory Affairs
- Pharmaceutical Nanotechnology: Challenges and Opportunities
- Pharmaceutical Research and Development
- Transdermal & Intradermal Drug Delivery Systems
- Wearable Drug Delivery